Skip to main content
Log in

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Twenty-six recurrent Glioblastoma (rGBM) patients sequentially treated at the National Neurological Institute ‘C Besta’ were enrolled for a second surgery in order to remove recurrent tumor and to place an Ommaya reservoire to allow local delivery of chemotherapy and local pre-targeted radio-immunotherapy (RIT). All patients had partial tumor resection and 75% of them had a residual tumor mass after exeresis larger than 2 cm. After surgery all patients were managed with a second line systemic chemotherapy (PCV). Moreover the protocol scheduled two cycles of local RIT (90 Yttrium 5– 25 mCi per cycle) with a 10 week interval. Locoregional mitoxantrone chemotherapy was locally delivered as a single dose of 4 mg every 20 days. Responses to treatment were assessed by monthly neurological examination and by MRI or contrast-enhanced CT scan performed every 2 months.

For the whole group of patients the PFS after second surgery at 6 and 12 months was 61% and 22%, respectively and survival after recurrence at 6, 12 and 18 months was 80%, 53% and 42%, respectively. Neither major side effects occurred systemically nor related on the place of local injections. The percentage of long-term survivors was very high: 42% of patients were still alive at 18 months. We stress the concept that the combined treatments could be more effective if delivered into a smaller residual tumor mass and probably in an adjuvant setting, before tumour recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MD Walker SB Green DP Byar Ejr Alexander U Batzdorf WH Brooks WE Hunt CS McCarty MS Mahavley SuffixJr J Mealey G Owens J Ransohoff JT Robertson WR Shapiro KR Smith SuffixJr CB Wilson TA Strike (1980) ArticleTitleRandomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1323–1327 Occurrence Handle1:STN:280:Bi6D2M3htF0%3D Occurrence Handle7001230

    CAS  PubMed  Google Scholar 

  2. HA Fine KBG Dear YS Loeffler PML Black GP Canellos (1993) ArticleTitleMeta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 2585–2597 Occurrence Handle1:STN:280:ByyB3c7kvVM%3D Occurrence Handle8453582

    CAS  PubMed  Google Scholar 

  3. InstitutionalAuthorNameEORTC Brain Tumor Group (1978) ArticleTitleEffect of CCNU on survival rate, objective remission and duration of free interval in patients with malignant brain glioma.Final evaluation. Eur J Cancer 14 851–856

    Google Scholar 

  4. PL Kornblith M Walker (1998) ArticleTitleChemotherapy for malignant gliomas J Neurosurg 68 1–17

    Google Scholar 

  5. T Tomita (1991) ArticleTitleInterstitial chemotherapy for brain tumors: review J Neuro-oncol 10 57–74 Occurrence Handle10.1007/BF00151247 Occurrence Handle1:STN:280:By6B3MjntFI%3D

    Article  CAS  Google Scholar 

  6. A Boiardi A Salmaggi A Pozzi G Broggi A Silvani (1996) ArticleTitleInterstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data J Neuro-oncol 27 157–162 Occurrence Handle10.1007/BF00177479 Occurrence Handle1:STN:280:BymB3svns10%3D

    Article  CAS  Google Scholar 

  7. A Boiardi A Silvani AL Pozzi L Fariselli G Broggi G Salmaggi (1999) ArticleTitleInterstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies J Neuro-oncol 41 151–157 Occurrence Handle10.1023/A:1006119505170 Occurrence Handle1:STN:280:DyaK1M3jvV2nsw%3D%3D

    Article  CAS  Google Scholar 

  8. H Brem S Piantadossi P Burger M Walker RW Selker NA Vick K Black M Sisti S Brem G Mohr P Muller R Morawetz SC Schold (1995) ArticleTitlecontrolled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas.The Polymer-brain Tumor Treatment Group. Lancet 345 1008–1012 Occurrence Handle10.1016/S0140-6736(95)90755-6 Occurrence Handle1:STN:280:ByqB2c%2FisVU%3D Occurrence Handle7723496

    Article  CAS  PubMed  Google Scholar 

  9. S Valtonen U Timonen P Toivanen H Kalimo L Kivipelto O Heiskanen G Usgaard T Kuurne (1997) ArticleTitleInterstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study Neurosurg 41 44–49 Occurrence Handle10.1097/00006123-199707000-00011 Occurrence Handle1:STN:280:ByiA287ktVQ%3D

    Article  CAS  Google Scholar 

  10. EP Sipos B Tyler S Piantadosi PC Burger H Brem (1997) ArticleTitleOptimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors Cancer Chemother Pharmacol 39 383–389 Occurrence Handle10.1007/s002800050588 Occurrence Handle1:CAS:528:DyaK2sXis1ajsb8%3D Occurrence Handle9054951

    Article  CAS  PubMed  Google Scholar 

  11. LK Fung MG Ewend A Sills EP Sipos R Thompson M Watts OM Colvin H Brem WM Salzman (1998) ArticleTitlePharmacokinetics of interstitial delivery of carmustine 4-hydroperoxycyclophosphamide and paclitaxel from a biodegradable polymer implant in the monkey brain Cancer Res 58 672–684 Occurrence Handle1:CAS:528:DyaK1cXht1antbY%3D Occurrence Handle9485020

    CAS  PubMed  Google Scholar 

  12. P Riva A Arista V Tison C Sturiale G Franceschi A Spinelli N Riva M Casi G Moscatelli M Frattarelli (1994) ArticleTitleIntralesional radioimmunotherapy of malignant gliomas.An effective treatment in recurrent tumors. Cancer 73 1076–1082 Occurrence Handle1:STN:280:ByuC3sfosVc%3D Occurrence Handle8306250

    CAS  PubMed  Google Scholar 

  13. G Paganelli M Bartolomei M Ferrari M Cremonesi G Broggi G Maira C Sturiale C Grana G Prisco M Gatti P Caliceti M Chinol (2001) ArticleTitlePre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results Cancer Biother Radiopharm 16 227–235 Occurrence Handle10.1089/10849780152389410 Occurrence Handle1:CAS:528:DC%2BD3MXlsV2qtLw%3D Occurrence Handle11471487

    Article  CAS  PubMed  Google Scholar 

  14. G Akabani CJ Reist I Cokgor AH Friedman HS Friedman RE Coleman XG Zhao DD Bigner MR Zalutsky (1999) ArticleTitleDosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors J Nucl Med 40 631–638 Occurrence Handle1:CAS:528:DyaK1MXisFOitrk%3D Occurrence Handle10210222

    CAS  PubMed  Google Scholar 

  15. P Perego A Boiardi N Carenini M De Cesare E Dolfini R Giardino I Magnani A Silvani C Soranzo (1994) ArticleTitleCharacterisation of an established human malignat glioblastoma cell line and its response to conventional grugs J Cancer Res Clin Oncol 120 585–592 Occurrence Handle10.1007/BF01212812 Occurrence Handle1:CAS:528:DyaK2MXis1yjurc%3D Occurrence Handle7929529

    Article  CAS  PubMed  Google Scholar 

  16. JP Jordan CM Hand RS Markowitz P Black (1992) ArticleTitleTest for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay J Neuro-oncol 14 19–35 Occurrence Handle10.1007/BF00170942 Occurrence Handle1:STN:280:ByyC3cfgtlw%3D

    Article  CAS  Google Scholar 

  17. M Senkal JC Tonn R Schonmayr W Schachenmayr U Eickhoff M Kemen E Kollig (1987) ArticleTitleMitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors J Neuro-oncol 32 203–208 Occurrence Handle10.1023/A:1005792410604

    Article  Google Scholar 

  18. DR MacDonald TL Cascino S Clifford (1990) ArticleTitleResponse criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277–1280 Occurrence Handle1:STN:280:By%2BB1MzotFM%3D Occurrence Handle2358840

    CAS  PubMed  Google Scholar 

  19. MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden PP Carbone (1982) ArticleTitleToxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649–655 Occurrence Handle1:STN:280:BiyC2cbntlU%3D Occurrence Handle7165009

    CAS  PubMed  Google Scholar 

  20. EL Kaplan P Meier (1958) ArticleTitleNonparametric estimation from incomplete observations J Am Stat Assoc 53 457–481

    Google Scholar 

  21. M Huncharek J Muscat (1998) ArticleTitleTreatment of recurrent high grade astrocytoma; results of a systematic review of 1415 patients Anticancer Res 18 1303–1312 Occurrence Handle1:STN:280:DyaK1c3nvVSnsw%3D%3D Occurrence Handle9615807

    CAS  PubMed  Google Scholar 

  22. A Boiardi M Eoli A Salmaggi B Zappacosta L Fariselli I Milanesi G Broggi A Silvani (2001) ArticleTitleEfficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumors J Neuro-oncol 54 39–47 Occurrence Handle10.1023/A:1012510513780 Occurrence Handle1:STN:280:DC%2BD38%2Fjtl2qsA%3D%3D

    Article  CAS  Google Scholar 

  23. C Nieder AL Grosu M Molls (2000) ArticleTitleA comparison of treatment results for recurrent malignant gliomas Cancer Treat Rev 26 397–409 Occurrence Handle10.1053/ctrv.2000.0191 Occurrence Handle1:STN:280:DC%2BD3M7gvVKitw%3D%3D Occurrence Handle11139371

    Article  CAS  PubMed  Google Scholar 

  24. M Brada K Hoang-Xuan R Rampling PY Dietrich LY Dirix D Macdonald JJ Heimans BA Zonnenberg JM Bravo-Marques R Henriksson R Stupp N Yue J Bruner M Dugan S Rao S Zaknoen (2001) ArticleTitlephase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 149–150 Occurrence Handle10.1023/A:1008382516636 Occurrence Handle11300316

    Article  PubMed  Google Scholar 

  25. AA Brandes M Ermani U Basso P Amista F Berti R Scienza A Rotilio G Pinna M Gardiman S Monfardini (2001) ArticleTitleTemozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study Ann Oncol 12 149–150 Occurrence Handle10.1023/A:1008382516636 Occurrence Handle11300316

    Article  PubMed  Google Scholar 

  26. J Dinnes C Cave S Huang R Milne (2002) ArticleTitleA rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma Br J Cancer 12 499–500

    Google Scholar 

  27. L Sipos D Vitanovics D Afra (2002) ArticleTitleTreatment of recidive malignant gliomas with temozolomide Orv Hetil 143 1201–1204 Occurrence Handle12073541

    PubMed  Google Scholar 

  28. DM Lieberman DW Laske PF Morrison KS Bankiewicz EH Oldfield (1995) ArticleTitleConvection-enhanced distribution of large molecules in gray matter during interstitial drug infusion J Neurosurg 82 1021–1029 Occurrence Handle1:CAS:528:DyaK2MXmsVGmsL8%3D Occurrence Handle7539062

    CAS  PubMed  Google Scholar 

  29. RJ White FE Durr (1985) ArticleTitleDevelopment of mitoxantrone Invest New Drugs 3 85–93 Occurrence Handle10.1007/BF00174154 Occurrence Handle1:CAS:528:DyaL2MXltlChs74%3D Occurrence Handle2410393

    Article  CAS  PubMed  Google Scholar 

  30. Green RM, Stewart DJ, Hugenholtz H, Richard MT, Thibault M, Montpetit V: Human central nervous system and plasma pharmacology of mitoxantrone. J Neuro-oncol: 75– 83,1988

  31. DJ Stewart RM Green NZ Mikhael V Montpetit M Thibault JA Maroun (1986) ArticleTitleHuman autopsy tissue concentration of mitoxantrone Cancer Treat Rep 70 1255–1261 Occurrence Handle1:STN:280:BiiD38fgt10%3D Occurrence Handle3768871

    CAS  PubMed  Google Scholar 

  32. G Broggi P Ferroli A Franzini A Silvani A Salmaggi M Eoli A Boiardi (2003) ArticleTitleLocal delivery of mitoxantrone for the treatment of malignant brain tumors in rats J Neurosurg 98 935–936 Occurrence Handle12691429

    PubMed  Google Scholar 

  33. P Riva A Arista G Franceschi M Frattarelli C Sturiale N Riva M Casi R Rossitti (1995) ArticleTitleLocal treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: comparison of the results obtained in recurrent and newly diagnosed tumors Cancer Res 55 5952–5956

    Google Scholar 

  34. P Riva G Franceschi N Riva M Casi M Santimaria M Adamo (2000) ArticleTitleRole of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach Eur J Nucl Med 27 601–609 Occurrence Handle10.1007/s002590050549 Occurrence Handle1:STN:280:DC%2BD3cvjs1antw%3D%3D Occurrence Handle10853818

    Article  CAS  PubMed  Google Scholar 

  35. H Proske DO Schachtschabel N Paul R Pfab (1992) ArticleTitleElectron microscopic studies on the effects of irradiation and mitoxantrone alone or in combination on cells of Harding Passey melanoma in monolayer culture Strahler Onkol 168 361–368 Occurrence Handle1:STN:280:By2A38%2FkslU%3D

    CAS  Google Scholar 

  36. C Linassier C Barin G Calais S Letortorec JL Bremond M Delain A Petit MT Georget G Cartron N Raban L Benboubker R Leloup C Binet JP Lamagnere P Colombat (2000) ArticleTitleEarly secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy Ann Oncol 11 1289–1294 Occurrence Handle10.1023/A:1008375016038 Occurrence Handle1:STN:280:DC%2BD3MzgsVKltA%3D%3D Occurrence Handle11106118

    Article  CAS  PubMed  Google Scholar 

  37. C Grana M Chinol C Robertson C Mazzetta M Bartolomei C De Cicco M Fiorenza M Gatti P Caliceti G Paganelli (2002) ArticleTitlePretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study Br J Cancer 21 207–212 Occurrence Handle10.1038/sj.bjc.6600047

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amerigo Boiardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boiardi, A., Bartolomei, M., Silvani, A. et al. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma. J Neurooncol 72, 125–131 (2005). https://doi.org/10.1007/s11060-004-1497-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-1497-5

Keywords

Navigation